10 Stocks With the Largest Fair Value Estimate Increases During Q3 Earnings
Morningstar analysts raised fair value estimates for 4.7% of covered stocks by 10%+ during Q3 earnings, with energy and healthcare sectors seeing the highest increases. Notable companies with significant fair value estimate hikes include Varonis Systems (VRNS), Lumentum Holdings (LITE), and Humana (HUM).
How this was made
The 30-second read
Why it matters
Analyst upgrades raise expectations for price appreciation, but the magnitude depends on deal execution and rating outcomes.
Market read
The upgrades collectively suggest modest bullish bias for the highlighted stocks.
What to watch
Potential regulatory or integration risks in the announced deals could temper upside.
Background
Morningstar released its latest fair‑value estimate updates for 10 U.S.-listed companies after Q3 earnings season.
Ticker impact
Morningstar raised Varonis fair value to $48 from $28 after a takeover offer.
potential upside as fair value estimate increases
Higher fair value reflects expected acquisition premium.
Fair value for Lumentum lifted to $1,255 from $750 following Marvell acquisition news.
potential upside as fair value estimate rises
Acquisition premium drives higher valuation.
Morningstar increased Tenable fair value to $35 from $23 after strong earnings and margin expansion.
potential upside as fair value estimate climbs
Improved profitability supports higher valuation.
Fair value for Range Resources raised to $66 from $46 amid EQT acquisition announcement.
potential upside as fair value estimate increases
Acquisition premium and strategic fit boost valuation.
Humana fair value lifted to $502 from $350 after a higher Medicare Advantage rating.
potential upside as fair value estimate rises
Improved star rating expected to drive earnings growth.
Morningstar raised BBVA fair value to $30 from $21 based on strong lending growth and net interest margins.
potential upside as fair value estimate climbs
Better-than-expected earnings drivers support higher valuation.
Corteva fair value increased to $20 from $15 after completing its seeds business spinoff.
potential upside as fair value estimate rises
Spin‑off clarifies business focus, improving outlook.
Morningstar raised Moderna fair value to $212 from $163 following recent data and pipeline progress.
potential upside as fair value estimate climbs
Pipeline developments boost growth expectations.
Market effects
Higher fair‑value upgrades across tech, healthcare and energy may lift sector sentiment.
U.S. and European markets could see modest buying in upgraded names.
Limited to the listed companies; no broad macro impact.
Counterpoint
Some upgrades may be premature if acquisition premiums or rating improvements fail to materialize.
Key entities
- companyVaronis Systems
Security software firm targeted by Proofpoint acquisition.
- companyLumentum Holdings
Optical components maker being acquired by Marvell.
- companyTenable Holdings
Cybersecurity firm with strong Q3 earnings.
- companyRange Resources
Oil & gas producer being bought by EQT.
- companyHumana
Health insurer with improved Medicare Advantage rating.
